Oryon Cell Therapies (Series A)
Funding Details
Awarder
Inbox
Date Award
March 23, 2026
Vertical
Biotechnology
Funding Amount
$21,000,000
Company Info
Founding Year
2020
Founders
Ole Isacson, M.D. Ph.D., Nikola Kojic, M.D. Ph.D.
Market
Neurodegenerative disorders
Location
Belmont, MA, USA
Coinvestors
Byers Capital, Neuro.VC
Company Description

Oryon Cell Therapies is a clinical-stage biotechnology company developing autologous cell therapies for neurodegenerative disorders, with an initial focus on Parkinson's disease. The company's technology is designed to restore synaptic function and motor control by replacing neurons lost to the disease, with the goal of achieving functional restoration.

Links